Neurotech Pharma's cell therapy Encelto has become the first FDA-approved treatment for idiopathic macular telangiectasia type 2 (MacTel), a rare eye disease leading to progressive and ...

Discover stocks' market position with detailed competitor analyses. Neurotech International Ltd. ( (AU:NTI)) just unveiled an update. Neurotech International Limited announced its participation in ...